Colgate-Palmolive (NYSE:CL) Receives $88.44 Consensus Target Price from Brokerages

Colgate-Palmolive (NYSE:CL) has received an average recommendation of “Moderate Buy” from the fifteen analysts that are currently covering the firm, MarketBeat Ratings reports. Three equities research analysts have rated the stock with a hold recommendation and twelve have assigned a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $89.50.

Several equities analysts have recently weighed in on CL shares. Morgan Stanley boosted their target price on Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a research report on Monday, January 29th. Stifel Nicolaus upped their price objective on Colgate-Palmolive from $89.00 to $94.00 and gave the company a “buy” rating in a research report on Wednesday, April 10th. UBS Group upped their price objective on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research report on Monday, January 29th. Barclays upped their price objective on Colgate-Palmolive from $82.00 to $84.00 and gave the company an “equal weight” rating in a research report on Friday, April 12th. Finally, Citigroup upped their price objective on Colgate-Palmolive from $95.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday.

Insider Buying and Selling at Colgate-Palmolive

In other news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total value of $4,157,500.00. Following the completion of the transaction, the chief executive officer now directly owns 274,179 shares in the company, valued at $22,797,983.85. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. In related news, CEO Noel R. Wallace sold 50,000 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $83.15, for a total transaction of $4,157,500.00. Following the sale, the chief executive officer now directly owns 274,179 shares of the company’s stock, valued at $22,797,983.85. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, EVP Gregory Malcolm sold 8,930 shares of the firm’s stock in a transaction dated Thursday, February 1st. The stock was sold at an average price of $85.35, for a total value of $762,175.50. Following the sale, the executive vice president now directly owns 8,043 shares in the company, valued at $686,470.05. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 232,371 shares of company stock worth $19,505,099. 0.37% of the stock is owned by insiders.

Institutional Trading of Colgate-Palmolive

Several institutional investors have recently bought and sold shares of CL. Vest Financial LLC boosted its stake in shares of Colgate-Palmolive by 25.1% in the fourth quarter. Vest Financial LLC now owns 370,071 shares of the company’s stock worth $29,498,000 after acquiring an additional 74,337 shares during the last quarter. Central Bank & Trust Co. lifted its position in Colgate-Palmolive by 22.1% during the fourth quarter. Central Bank & Trust Co. now owns 1,383 shares of the company’s stock worth $110,000 after buying an additional 250 shares in the last quarter. Dynamic Advisor Solutions LLC lifted its position in Colgate-Palmolive by 9.2% during the fourth quarter. Dynamic Advisor Solutions LLC now owns 10,808 shares of the company’s stock worth $864,000 after buying an additional 910 shares in the last quarter. Sarasin & Partners LLP lifted its position in Colgate-Palmolive by 1.2% during the fourth quarter. Sarasin & Partners LLP now owns 4,053,634 shares of the company’s stock worth $323,115,000 after buying an additional 49,980 shares in the last quarter. Finally, Cornerstone Wealth Management LLC lifted its position in Colgate-Palmolive by 2.5% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,170 shares of the company’s stock worth $571,000 after buying an additional 172 shares in the last quarter. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Down 0.0 %

Shares of CL opened at $86.16 on Friday. The stock has a market capitalization of $70.82 billion, a price-to-earnings ratio of 30.99, a price-to-earnings-growth ratio of 3.26 and a beta of 0.42. Colgate-Palmolive has a 1 year low of $67.62 and a 1 year high of $90.37. The business’s 50 day simple moving average is $86.92 and its 200-day simple moving average is $80.58. The company has a debt-to-equity ratio of 8.59, a current ratio of 1.11 and a quick ratio of 0.71.

Colgate-Palmolive (NYSE:CL) last released its earnings results on Friday, January 26th. The company reported $0.87 earnings per share for the quarter, beating the consensus estimate of $0.85 by $0.02. The firm had revenue of $4.95 billion for the quarter, compared to the consensus estimate of $4.89 billion. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company’s revenue for the quarter was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.77 EPS. As a group, equities analysts expect that Colgate-Palmolive will post 3.49 earnings per share for the current fiscal year.

Colgate-Palmolive Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Investors of record on Monday, April 22nd will be paid a dividend of $0.50 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.48. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.32%. The ex-dividend date is Friday, April 19th. Colgate-Palmolive’s dividend payout ratio is 69.06%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.